PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7963457

Pseudobacteraemia.

P A Jumaa·B Chattopadhyay
View original source ↗Export metadata ↓

Abstract

Pseudobacteraemia occurs when bacteria isolated from blood cultures have originated from outside the patient's bloodstream. Failure to recognize that pseudobacteraemia is taking place and is not true infection may result in patient morbidity, unnecessary therapy and a significant waste of health care resources. Pseudobacteraemia may occur as a result of contamination introduced at any stage of blood culturing, from taking the blood to processing it in the laboratory. In most reported cases, contamination has occurred as a result of faulty aseptic technique, and thus pseudobacteraemia is usually preventable. Episodes of pseudobacteraemia require prompt investigation, but their recognition may be extremely difficult. Here we review pseudobacteraemia and recommend guidelines for its recognition, investigation and prevention.

Explore related subjects

BacteremiaBacteriaBacteriological TechniquesBloodBlood Specimen CollectionBloodlettingEquipment ContaminationHumansIncidenceComparative StudyJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P A Jumaa, B Chattopadhyay. 1994. Pseudobacteraemia.. https://doi.org/10.1016/0195-6701(94)90124-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2017

Route of infection alters virulence of neonatal septicemia Escherichia coli clinical isolates.

Escherichia coli is the leading cause of Gram-negative neonatal septicemia in the United States. Invasion and passage across the neonatal gut after ingestion of maternal E. coli strains produce bacteremia. In this study, we compared the virulence properties of the neonatal E. coli bacteremia clinical isolate SCB34 with the archetypal neonatal E. coli meningitis strain RS218. Whole-genome sequencing data was used to compare the protein coding sequences among these clinical isolates and 33 other representative E. coli strains. Oral inoculation of newborn animals with either strain produced septicemia, whereas intraperitoneal injection caused septicemia only in pups infected with RS218 but not in those injected with SCB34. In addition to being virulent only through the oral route, SCB34 demonstrated significantly greater invasion and transcytosis of polarized intestinal epithelial cells in vitro as compared to RS218. Protein coding sequences comparisons highlighted the presence of known virulence factors that are shared among several of these isolates, and revealed the existence of proteins exclusively encoded in SCB34, many of which remain uncharacterized. Our study demonstrates that oral acquisition is crucial for the virulence properties of the neonatal bacteremia clinical isolate SCB34. This characteristic, along with its enhanced ability to invade and transcytose intestinal epithelium are likely determined by the specific virulence factors that predominate in this strain.

Bacteremia↗
PubMed1997

Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency.

During a 30-month interval at LeBonheur Children's Medical Center, 394 patients had a blood or cerebrospinal fluid culture positive for Streptococcus pneumoniae. Sixteen of these episodes (4%) were repeated infections; 6 of these 16 patients had sickle cell disease. Six of the remaining 10 patients had immunologic evaluations of varying completeness; no immunodeficiency was identified by these tests or on follow-up. Nine of the ten previously healthy patients with repeated pneumococcal disease were less than 2 years of age. In our experience, repeated invasive pneumococcal infections in otherwise healthy young children were relatively common (10/394, or 2.5% of patients with invasive pneumococcal infections) and did not indicate the presence of an unsuspected immunodeficiency.

Bacteremia↗
PubMed1997

An analysis of two prevalence surveys of nosocomial infection in German intensive care units.

In 1995, the results of two extensive prevalence studies on hospital-acquired infections were published. Both studies included a prevalence component for German intensive care units (ICUs), but provided very different infection rates. A comparison of the methods used revealed that the data from the ICUs included in the German section of EPIC (European Prevalence of Infection in Intensive Care), reflected the situation in the ICUs of large hospitals. The situation in ICUs with fewer than 600 beds was quite different, and led to the lower overall rate of infection as seen in the NIDEP (Nosocomial Infections in Germany-Surveillance and Prevention) study. Additionally, the NIDEP data permitted the calculation of device-associated, device-day, infection rates for urinary tract infections, pneumonia and bacteraemia. The differences between the ICUs in the two hospital groups were mainly due to a lower use of patient devices with regard to urinary catheters, central venous lines and respiratory ventilators.

Bacteremia↗